Ikena Oncology, Inc..
IKNA.US | Research and experimental development on natural sciences and engineering
Ikena Oncology, Inc. is a targeted oncology company focused on developing novel therapies that target key signaling pathways that drive cancer progression. The company's pipeline includes programs targeting the Hippo signaling pathway and the RAS signaling pathway, both of which are implicated in a ...Show More
Better Health for All
-30
Ikena Oncology's core business is entirely devoted to developing novel therapies for cancer, with its pipeline focused on IK-595 for RAS and RAF mutant cancers, which aligns with a business strategy centered on health improvement.
1
However, the company has undertaken significant workforce reductions, terminating approximately 18 employees (53% of its workforce) by the end of Q3, following an earlier 35% reduction (approximately 20 employees) in January.
2
Regarding clinical trial ethics, the company's trials for IK-930 and IK-595 are described as being in patients with solid tumors and RAS/RAF mutant cancers, respectively, without explicit mention of efforts to ensure diverse representation in trial populations.
3
Fair Money & Economic Opportunity
0
No evidence available to assess Ikena Oncology, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No regulatory actions, violations, fines, or compliance issues related to labor laws or human rights are mentioned in the provided articles.
1
While the company offers benefits such as fully covered health insurance premiums, a 401K plan with a company match, 15 days of PTO plus 12 holidays, unlimited sick days, an HSA with a generous company contribution, anniversary celebrations, tuition reimbursement, and daily lunch, there is no specific data on the percentage of the workforce covered by health insurance or other benefits, nor on other quantitative metrics like living wage coverage, CEO-to-median pay ratio, collective bargaining, safety incident rates, pay equity, worker engagement, or turnover rate.
2
Fair Trade & Ethical Sourcing
0
No evidence available to assess Ikena Oncology, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, quantifiable evidence was found in the provided articles to assess Ikena Oncology against any of the 'Honest & Fair Business' KPIs. Information regarding regulatory fines, transparency index, whistleblower policy, financial restatements, audit coverage, ESG controversy index, complaint resolution time, board conflict-free percentage, anti-corruption policy, or third-party verification was either explicitly stated as 'Not available' or lacked the necessary detail to map to the rubric's quantitative thresholds.
1
Kind to Animals
-20
IKNA.US conducts preclinical studies of its drugs on animals to assess product safety and efficacy.
1
This practice is a standard part of their drug development process, as confirmed by multiple sources stating that preclinical testing involves animal models to assess drug safety and a product’s safety profile.
2
There is no evidence of a policy to reduce or restrict animal testing beyond what is legally mandated, nor any mention of a policy prohibiting discretionary testing.
3
No War, No Weapons
0
No relevant information was found in the provided article to assess IKNA.US against the 'No War, No Weapons' ethical value.
1
The article content was an error message.
2
Planet-Friendly Business
0
No specific, concrete data points were found in the provided articles that directly align with the quantitative thresholds of the 'Planet-Friendly Business' KPIs. Information regarding environmental performance, targets, or initiatives was either not specified, not directly measurable against the rubric's criteria, or represented as a reduction in a metric rather than the metric itself (e.g., waste reduction vs. waste diversion rate).
1
Therefore, no KPIs could be scored.
Respect for Cultures & Communities
0
No evidence available to assess Ikena Oncology, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
No evidence available to assess Ikena Oncology, Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No evidence available to assess Ikena Oncology, Inc. on Zero Waste & Sustainable Products.